 Connection
Donald Bodenner to Thyroid Neoplasms
This is a "connection" page, showing publications Donald Bodenner has written about Thyroid Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.002 |
|
|
|
-
Frank RW, Middleton L, Stack BC, Spencer HJ, Riggs AT, Bodenner DL. Conservative management of thyroglobulin-positive, nonlocalizable thyroid carcinoma. Head Neck. 2014 Feb; 36(2):155-7.
Score: 0.380
-
Bodenner D, Nalley C, Chien C, Clarke B, Spring PM, Stack BC. Markedly elevated serum calcitonin concentrations associated with initial presentation but not the recurrent presentation of medullary thyroid carcinoma. Thyroid. 2010 Aug; 20(8):927-9.
Score: 0.312
-
King DL, Stack BC, Spring PM, Walker R, Bodenner DL. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg. 2007 Sep; 137(3):400-4.
Score: 0.255
-
Hinson AM, Massoll NA, Jolly LA, Stack BC, Bodenner DL, Franco AT. Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis. Head Neck. 2017 08; 39(8):1639-1646.
Score: 0.125
-
Fitzgerald RT, Kuruva M, David R, Samant RS, Kumar M, Van Hemert R, Angtuaco EJ, Bodenner D, Stack BC. Characterization of Thyroid Nodules by 4-Dimensional Computed Tomography: Initial Experience. J Comput Assist Tomogr. 2017 Mar/Apr; 41(2):195-198.
Score: 0.123
-
Schlumberger M, Jarzab B, Cabanillas ME, Robinson B, Pacini F, Ball DW, McCaffrey J, Newbold K, Allison R, Martins RG, Licitra LF, Shah MH, Bodenner D, Elisei R, Burmeister L, Funahashi Y, Ren M, O'Brien JP, Sherman SI. A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer. Clin Cancer Res. 2016 Jan 01; 22(1):44-53.
Score: 0.111
-
Hinson AM, Kandil E, O'Brien S, Spencer HJ, Bodenner DL, Hohmann SF, Stack BC. Trends in Robotic Thyroid Surgery in the United States from 2009 Through 2013. Thyroid. 2015 Aug; 25(8):919-26.
Score: 0.110
-
Cabanillas ME, Schlumberger M, Jarzab B, Martins RG, Pacini F, Robinson B, McCaffrey JC, Shah MH, Bodenner DL, Topliss D, Andresen C, O'Brien JP, Ren M, Funahashi Y, Allison R, Elisei R, Newbold K, Licitra LF, Sherman SI, Ball DW. A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment. Cancer. 2015 Aug 15; 121(16):2749-56.
Score: 0.108
-
Stack BC, Bodenner DL, Bartel TB, Boeckmann J. Focal thyroid uptake on 18F-fluorodeoxyglucose positron emission tomography: interpreting the data. Thyroid. 2013 May; 23(5):636-7.
Score: 0.094
-
Collins AM, Bodenner D, Chen C, Stone P, Stack BC. Delayed treatment of papillary thyroid carcinoma arising from struma ovarii in a patient with history of bilateral salpingo-oophorectomy: a case report. Endocr Pract. 2012 Jan-Feb; 18(1):e1-4.
Score: 0.086
-
Francis CL, Nalley C, Fan C, Bodenner D, Stack BC. 18F-fluorodeoxyglucose and 131I radioguided surgical management of thyroid cancer. Otolaryngol Head Neck Surg. 2012 Jan; 146(1):26-32.
Score: 0.085
-
Nalley C, Wiebeck K, Bartel TB, Bodenner D, Stack BC. Intraoperative radiation exposure with the use of (18)F-FDG-guided thyroid cancer surgery. Otolaryngol Head Neck Surg. 2010 Feb; 142(2):281-3.
Score: 0.075
-
Allen SM, Bodenner D, Suen JY, Richter GT. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma. Laryngoscope. 2009 Jul; 119(7):1303-11.
Score: 0.072
-
Smith JA, Fan CY, Zou C, Bodenner D, Kokoska MS. Methylation status of genes in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2007 Oct; 133(10):1006-11.
Score: 0.064
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|